X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Glucose-6-phosphate dehydrogenase (G6PD) is important in the control of oxidant stress in erythrocytes, the host cells for Plasmodium falciparum. Mutations in this enzyme produce X-linked deficiency states associated with protection against malaria, notably in Africa where the A- form of G6PD deficiency is widespread. Some reports have proposed that heterozygous females with mosaic populations of normal and deficient erythrocytes (due to random X chromosome inactivation) have malaria resistance similar to or greater than hemizygous males with populations of uniformly deficient erythrocytes. These proposals are paradoxical, and they are not consistent with currently hypothesized mechanisms of protection. METHODS AND FINDINGS: We conducted large case-control studies of the A- form of G6PD deficiency in cases of severe or uncomplicated malaria among two ethnic populations of rural Mali, West Africa, where malaria is hyperendemic. Our results indicate that the uniform state of G6PD deficiency in hemizygous male children conferred significant protection against severe, life-threatening malaria, and that it may have likewise protected homozygous female children. No such protection was evident from the mosaic state of G6PD deficiency in heterozygous females. We also found no significant differences in the parasite densities of males and females with differences in G6PD status. Pooled odds ratios from meta-analysis of our data and data from a previous study confirmed highly significant protection against severe malaria in hemizygous males but not in heterozygous females. Among the different forms of severe malaria, protection was principally evident against cerebral malaria, the most frequent form of life-threatening malaria in these studies. CONCLUSIONS: The A- form of G6PD deficiency in Africa is under strong natural selection from the preferential protection it provides to hemizygous males against life-threatening malaria. Little or no such protection is present among heterozygous females. Although these conclusions are consistent with data from at least one previous study, they have not heretofore been realized to our knowledge, and they therefore give fresh perspectives on malaria protection by G6PD deficiency as an X-linked trait.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a similar fashion, hemizygous males and healthy heterozygous females carrying a mutation in the G6PD (for glucose-6-phasphate dehydrogenase) gene are protected from severe malaria (Guindo et al., 2007).”
From Iron in infection and immunity (2020) · cites this paper as Guindo et al., 2007
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“It is likely that a similar mechanism underlies the protective effect exerted by other chronic hemolytic conditions against malaria, including hemoglobin C [229,230], glucose 6 phosphate dihydrogenase (G6PD) deficiency in males [231], bor a-thalassemia [230] as well as mutations involved in RBC cytoskeleton or membrane protein defects [232].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [231]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common West African HLA antigens are associated with protection from severe malaria
Hill, A. V. S., Allsopp, C. E. M., Kwiatkowski, D., Anstey, N. M., Twumasi, P., Rowe, P. A., Bennett, S., Brewster, D., McMichael, A. J., & Greenwood, B. M. (1991) · Nature · doi:10.1038/352595a0 · Cited by 1,552 · cited 6×
“Mutant hemoglobins also contribute to protection against severe malaria in West Africa [13,18,19].”
BackgroundResultInfluentialSatpathy, S. K., Mohanty, N., Nanda, P., & Samal, G. (2004) · The Indian Journal of Pediatrics · doi:10.1007/bf02723094 · Cited by 1,130
Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster.
(2000) · PubMed · Cited by 1,069
Protective effects of the sickle cell gene against malaria morbidity and mortality
Aidoo, M., Terlouw, D. J., Kolczak, M. S., McElroy, P. D., ter Kuile, F. O., Kariuki, S., Nahlen, B. L., Lal, A. A., & Udhayakumar, V. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08273-9 · Cited by 700 · cited 1×
“much-reduced morbidity and mortality rates in children after the first few years of life [16,17].”
BackgroundTishkoff, S. A., Varkonyi, R., Cahinhinan, N., Abbes, S., Argyropoulos, G., Destro-Bisol, G., Drousiotou, A., Dangerfield, B., Lefranc, G., Loiselet, J., et al. (2001) · Science · doi:10.1126/science.1061573 · Cited by 630 · cited 1×
“*A− allele arose within the past 3,840–11,760 years and spread with agriculture and malaria in Africa [”
BackgroundRuwende, C., Khoo, S. C., Snow, R. W., Yates, S. N. R., Kwiatkowski, D., Gupta, S., Warn, P., Allsopp, C. E. M., Gilbert, S. C., Peschu, N., et al. (1995) · Nature · doi:10.1038/376246a0 · Cited by 595 · cited 8×
“[5] for evidence of protection against two leading forms of severe malaria highly fatal to African children, cerebral malaria and severe anemia.”
BackgroundMethodResultInfluentialHaemoglobin C protects against clinical Plasmodium falciparum malaria
Modiano, D., Luoni, G., Sirima, B. S., Simporé, J., Verra, F., Konaté, A., Rastrelli, E., Olivieri, A., Calissano, C., Paganotti, G. M., et al. (2001) · Nature · doi:10.1038/35104556 · Cited by 381
Cappadoro, M., Giribaldi, G., O'Brien, E., Turrini, F., Mannu, F., Ulliers, D., Simula, G., Luzzatto, L., & Arese, P. (1998) · Blood · doi:10.1182/blood.v92.7.2527 · Cited by 339
The burden of malaria mortality among African children in the year 2000
Rowe, A. K., Rowe, S. Y., Snow, R. W., Korenromp, E. L., Schellenberg, J. R. A., Stein, C., Nahlen, B. L., Bryce, J., Black, R. E., & Steketee, R. W. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl027 · Cited by 302 · cited 1×
“In rural villages of West Africa where malaria is hyperendemic and adequate medication can be difficult to obtain, virtually all children experience malaria episodes early in life, and approximately 20% die from the disease by age five [12].”
BackgroundMetabolic polymorphisms and the role of infectious diseases in human evolution.
Motulsky, A. G. (1960) · PubMed · Cited by 277
Cited by
Items 101–200 of 280
Overview of human genetic susceptibility to malaria: From parasitemia control to severe disease
Marquet, S. (2017) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2017.06.001 · Cited by 26
A non-canonical sensing pathway mediates Plasmodium adaptation to amino acid deficiency
Marreiros, I. M., Marques, S., Parreira, A., Mastrodomenico, V., Mounce, B. C., Harris, C. T., Kafsack, B. F. C., Billker, O., Zuzarte‐Luís, V., & Mota, M. M. (2023) · Communications Biology · doi:10.1038/s42003-023-04566-y · Cited by 21
Coelho, P. M. B. M., Salvador, A., & Savageau, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013031 · Cited by 23
“first suggested that individuals deficient in G6PD might be at a selective advantage in malaria endemic areas. However, numerous clinical studies have yielded conflicting results over the alleged protective role of G6PD deficiency against malaria. In particular, clinical studies of severe malaria have shown a protecti…”
ResultLwanira, C. N., Kironde, F., Kaddumukasa, M., & Swedberg, G. (2017) · Malaria Journal · doi:10.1186/s12936-017-1970-1 · Cited by 21
“While the protective effect of the HbAS against malaria seems to be clearer, associations with G6PD deficiency vary widely in the different studies, with protection observed in females [14, 15], in males [16], in both [17] and no protection at all [18, 19].”
BackgroundLey, B., Alam, M. S., Kibria, M. G., Marfurt, J., Phru, C. S., Ami, J. Q., Thriemer, K., Auburn, S., Jahan, N., Johora, F. T., et al. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003576 · Cited by 21
Gunawardena, S., Kapilananda, G. M. G., Samarakoon, D., Maddevithana, S., Wijesundera, S., Goonaratne, L. V., & Karunaweera, N. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171208 · Cited by 18
Heritability of P. falciparum and P. vivax Malaria in a Karen Population in Thailand
Phimpraphi, W., Paul, R. E. L., Witoonpanich, B., Turbpaiboon, C., Peerapittayamongkol, C., Cheepsunthorn, C. L., Casadémont, I., Tungpradabkul, S., Krudsood, S., Kaewkunwal, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003887 · Cited by 20
Zhang, Z., Chen, X., Jiang, C., Fang, Z., Feng, Y., & Jiang, W. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.02.010 · Cited by 17
Yi, H., Li, H., Liang, L., Wu, Y., Zhang, L., Qiu, W., Jiang, W., Yang, F., Li, Q., Yang, Z., et al. (2019) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2019.103980 · Cited by 23
“falciparum infection and cerebral malaria (Bienzle et al., 1972; Guindo et al., 2007; Ruwende et al., 1995; Shah et al., 2016), the pictures for other G6PD variants are less clear and evidence Yi et al.”
BackgroundDePina, A. J., Pires, C. M., Andrade, A. J. B., Dia, A. K., Moreira, A. L., Ferreira, M. C. M., Correia, A. J., Faye, O., Seck, I., & Niang, E. H. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229574 · Cited by 17
Prevalence and hematological indicators of G6PD deficiency in malaria-infected patients
Kotepui, M., Uthaisar, K., PhunPhuech, B., & Phiwklam, N. (2016) · Infectious Diseases of Poverty · doi:10.1186/s40249-016-0130-0 · Cited by 21
“The reason for this difference in protection is not clear, as it is not known how malaria parasites are affected by RBCs that lack G6PD activity [22].”
BackgroundPeters, A. L., Veldthuis, M., van Leeuwen, K., Bossuyt, P. M., Vlaar, A. P. J., van Bruggen, R., de Korte, D., Noorden, C. J. F. V., & van Zwieten, R. (2017) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155417730021 · Cited by 17
Red blood cell variants and malaria: a long story not yet over
Williams, T. N. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00049-6 · Cited by 17
Guindo, A., Traoré, K., Diakité, S. A. S., Wellems, T. E., Doumbo, O. K., & Diallo, D. A. (2011) · American Journal of Hematology · doi:10.1002/ajh.22093 · Cited by 16
“Microscopic confirmations of parasitemia, assignments of the cases into uncomplicated or severe malaria, and hemoglobin typing and G6PD (A2) detection were as described [9].”
BackgroundMethodInfluentialSelf-citationWélé, M., DJIMDÉ, A. A., Guindo, A., Béavogui, A. H., Traoré, I. Z., Sadou, A., Dackouo, B., Diallo, D. A., Wellems, T. E., & Doumbo, O. K. (2011) · Acta Tropica · doi:10.1016/j.actatropica.2011.01.002 · Cited by 15
Self-citationHe, M., Lin, K., Huang, Y., Zhou, L., Yang, Q., Li, S., & Jiang, W. (2018) · Human Heredity · doi:10.1159/000489009 · Cited by 16
Islam, M. T., Sarker, S. K., Talukder, S., Bhuyan, G. S., Rahat, A., Islam, N. N., Mahmud, H., Hossain, M. A., Muraduzzaman, A. K. M., Rahman, J., et al. (2018) · BMC Genetics · doi:10.1186/s12863-018-0664-1 · Cited by 14
Amoah, L. E., Asare, K. K., Donu, D., Abankwa, J., Busayo, A., Bredu, D., Annan, S., Asumah, G. A., Peprah, N. Y., Asamoah, A., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257562 · Cited by 18
“falciparum-infected individuals from severe malaria [16, 48].”
ResultAwandu, S. S., Raman, J., Makhanthisa, T. I., Kruger, P. S., Frean, J., Bousema, T., Niemand, J., & Birkholtz, L. (2018) · Malaria Journal · doi:10.1186/s12936-018-2271-z · Cited by 14
“Whilst earlier studies reported G6PD deficiency protection against severe forms of malaria [10, 11], recent data from a large multi-centre case control study and a meta-analysis suggests protection from cerebral malaria and high parasitaemia and not severe malarial anaemia, mainly in heterozygous individuals in Africa…”
ResultWankaew, N., Chariyavilaskul, P., Chamnanphon, M., Assawapitaksakul, A., Chetruengchai, W., Pongpanich, M., & Shotelersuk, V. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263621 · Cited by 13
Sam, M. (2012) · InTech eBooks · doi:10.5772/34826 · Cited by 14
Zúñiga, M. A., Mejía, R. E., Sanchez, A. L., Ochoa, W. H. S., & Fontecha, G. A. (2015) · Malaria Journal · doi:10.1186/s12936-015-0823-z · Cited by 15
The prevalence of glucose-6-phosphate dehydrogenase deficiency in Gambian school children
Okebe, J., Amambua‐Ngwa, A., Parr, J., Nishimura, S., Daswani, M., Takem, E. N., Affara, M., Ceesay, S. J., Nwakanma, D. C., & D’Alessandro, U. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-148 · Cited by 19
“G6PDd has been associated with a protective effect against severe malaria [24] in males but not in females [25] and has been associated with multiple mutations rather than a specific mutant genotype [10].”
BackgroundKakande, E. R., Greenhouse, B., Bajunirwe, F., DRAKELEY, C. J., Nankabirwa, J. I., Walakira, A., Nsobya, S. L., Katureebe, A., Rek, J. C., Arinaitwe, E., et al. (2020) · Malaria Journal · doi:10.1186/s12936-020-3105-3 · Cited by 15
Martin, S., Samuel, M., Stow, D., Ridsdale, A. M., Chen, J., Young, K., Green, H., Hattersley, A. T., L’Esperance, V., McKinley, T. J., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0556 · Cited by 18
“The majority of those affected descend from Africa, Asia, the Middle East and Mediterranean regions, due to its evolutionary advantage in conferring protection against severe malaria(6).”
Bwayo, D., Kaddumukasa, M., Ddungu, H., & Kironde, F. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-372 · Cited by 18
“Funding This study was funded by the African Malaria Network Trust (AMANET) Malaria vaccine trial site capacity building grant and SIDA-SAREC grant for Makerere University.”
ResultInfluentialAlencar, N., Sola, I., Linares, M., Juárez‐Jiménez, J., Pont, C., Viayna, A., Vílchez, D., Sampedro, C., Abad, P., Pérez-Benavente, S., et al. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.01.044 · Cited by 16
Huang, H., Dong, Y., Xu, Y., Deng, Y., Zhang, C., Liu, S., Chen, M., & Liu, Y. (2021) · Malaria Journal · doi:10.1186/s12936-021-03685-3 · Cited by 12
Miura, K., Diakité, M., Diouf, A., Doumbia, S., Konate, D. S., Keita, A. S., Moretz, S. E., Tullo, G., Zhou, H., Lopera-Mesa, T. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060182 · Cited by 15
Self-citationBrandt, O., Rieger, A., Geusau, A., & Stingl, G. (2008) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2008.06640.x · Cited by 13
G6PD gene variants and its association with malaria in a Sri Lankan population
Dewasurendra, R., Rockett, K. A., Fernando, S. D., Carter, R., Kwiatkowski, D. P., & Karunaweera, N. D. (2015) · Malaria Journal · doi:10.1186/s12936-015-0603-9 · Cited by 13
“However, in two studies done in Mali and Pakistan there was no such association between heterozygous females and severe malaria which is believed to be due to the control group being individuals with ‘uncomplicated malaria’ compared to the cases of severe and complicated malaria [8,26,28].”
BackgroundResultInfluentialMiscellanea on Encephalopathies
Legname, G., & Zanusso, G. (2012) · InTech eBooks · doi:10.5772/1191 · Cited by 11
Peters, A. L., & Noorden, C. J. F. V. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6788-9_1 · Cited by 11
G6PD A−variant influences the antibody responses to Plasmodium falciparum MSP2
Courtin, D., Milet, J., Bertin, G. I., Homann, M. V., Sarr, J. B., Watier, L., Deloron, P., Troye‐Blomberg, M., Garcia, A., & Migot‐Nabias, F. (2011) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2011.04.016 · Cited by 10
“It is well known that children harbouring HBB AS, a(+)thalassemia or G6PD A variants are protected against uncompli- cated or severe malaria (Aidoo et al., 2002; Cappadoro et al., 1998; Enevold et al., 2008; Guindo et al., 2007; Ruwende et al., 1995; Wambua et al., 2006; Williams et al., 2005).”
BackgroundAnaemia in a phase 2 study of a blood stage falciparum malaria vaccine
Ellis, R. D., Fay, M. P., Sagara, I., Dicko, A., Miura, K., Guindo, M. A., Guindo, A., Sissoko, M. S., Doumbo, O. K., & Diallo, D. A. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-13 · Cited by 11
“Similarly, G6PD status is a potential confounder for anaemia [13] and was included in the model.”
BackgroundSelf-citationWilliams, T. (2016) · Wiley eBooks · doi:10.1002/9781118493816.ch17 · Cited by 10
HbS Protection from P. falciparum Infection
Eridani, S. (2013) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2013/2427 · Cited by 10
“As the gene coding for G6PD is carried on the X chromosome, the mutation in G6PD-A that leads to the G6PD-A− deficiency actually gives substantial protection against severe malaria to boys, who have all copies of the enzyme affected by the mutation, but not to girls, who have a heterozygous, mosaic state of G6PD-defic…”
BackgroundPrevalence of HIV and malaria: a cross-sectional study on Bioko Island, Equatorial Guinea
Zheng, X., Lin, M., Xie, D., Li, J., Chen, J., Eyi, U. M., Monte‐Nguba, S., EHAPO, J. C. S., Yang, H., Yang, H.-T., et al. (2017) · African Journal of AIDS Research · doi:10.2989/16085906.2016.1257495 · Cited by 10
Khammanee, T., Sawangjaroen, N., Buncherd, H., Tun, A. W., & Thanapongpichat, S. (2022) · Korean Journal of Parasitology · doi:10.3347/kjp.2022.60.1.15 · Cited by 16
“hemizygous males [9] or heterozygous female children [10].”
BackgroundErhabor, O., Mainasara, Dallatu, Bilbis, Adias, T. C., Omojuyigbe, & Issac (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s43757 · Cited by 17
“A number of epidemiological studies have associated SCT or G6PD deficiency with protection against malaria, in particular severe, life-threatening malaria in its cerebral form.(20,21) G6PD deficiency is an X-linked condition associated with damage to red blood cells and hemolysis in response to a variety of exposures,…”
BackgroundGlucose-6-phosphate dehydrogenase status and severity of malarial anaemia in Nigerian children
Orimadegun, A. E., & Sodeinde, O. (2011) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.1837 · Cited by 10
“The lack of difference in the parasite rate between G6PD deficient and normal female malarial patients was previously reported [24].”
BackgroundResultPlewes, K., Soontarawirat, I., Ghose, A., Bancone, G., Kingston, H. W. F., Herdman, M. T., Leopold, S. J., Ishioka, H., Faiz, M. A., Anstey, N. M., et al. (2017) · Malaria Journal · doi:10.1186/s12936-017-1788-x · Cited by 11
Liang, X., Chen, J., Ma, Y., Huang, H., Xie, D., Monte‐Nguba, S., Ehapo, C. S., Eyi, U. M., Zheng, Y., Liu, X., et al. (2019) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1061 · Cited by 14
Nasr, A., Saleh, A., Eltoum, M., Abushouk, A., Hamza, A., Aljada, A., El-toum, M. E., Abu‐Zeid, Y. A., Allam, G. A., & ElGhazali, G. E. (2018) · Acta Tropica · doi:10.1016/j.actatropica.2018.02.030 · Cited by 12
Biological Constraint as a Cause of AgingPreprint
Gems, D., & Kern, C. C. (2022) · Preprints.org · doi:10.20944/preprints202205.0212.v1 · Cited by 10
Boonyuen, U., Jacob, B. A. C., Wongwigkan, J., Chamchoy, K., Singha-art, N., Pengsuk, N., Songdej, D., Adams, E. R., Edwards, T., Chamnanchanunt, S., et al. (2024) · Malaria Journal · doi:10.1186/s12936-024-04864-8 · Cited by 11
Wickham, K. S., Baresel, P. C., Marcsisin, S. R., Sousa, J. C., Vuong, C. T., Reichard, G. A., Campo, B., Tekwani, B. L., Walker, L., & Rochford, R. A. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00600-16 · Cited by 9
“In countries such as Mali and Nigeria, where the A variant accounted for 100% of screened populations in large case control studies, single-dose PQ could potentially be distributed without G6PD testing and without posing a significant risk to G6PDd individuals (26, 27).”
BackgroundFrequency of G6PD Mediterranean in individuals with and without malaria in Southern Pakistan
Moiz, B., Arshad, H. M., Raheem, A., Hayat, H., Ghanchi, N. K., & Beg, M. (2017) · Malaria Journal · doi:10.1186/s12936-017-2069-4 · Cited by 17
“For example, in Africa, G6PD A-type offers relative protection against falciparum malaria in hemizygous males and to some extent in heterozygous females [6].”
BackgroundGlucose-6-phosphate Dehydrogenase Deficiency
Lee, J. M. (2015) · Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology · doi:10.15264/cpho.2015.22.1.1 · Cited by 10
“감비아와 케냐에서는 남성과 여 성 모두에게, 말리에서는 남성에게만 저항력이 있는 것으로 각각 보고되었는데 이는 지역에 따른 유전적 변이의 차이로 인한 것으로 여겨진다[8,9].”
Uthman, O. A., Saunders, R., Sinclair, D., Graves, P. M., Gelband, H., Clarke, A., & Garner, P. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004664 · Cited by 7
Thiam, F., Diop, G., Coulonges, C., Derbois, C., Mbengue, B., Thiam, A., Nguer, C. M., Zagury, J., Deleuze, J., & Diéye, A. (2022) · PeerJ · doi:10.7717/peerj.13487 · Cited by 9
“Indeed the A-allele of G6PD-202 G > A polymorphism has been associated with protection against severe malaria in African populations, such as in Mali, the Gambia and Uganda (Guindo et al., 2007; Ruwende et al., 1995).”
BackgroundInfluentialZeituni, A. E., Miura, K., Diakité, M., Doumbia, S., Moretz, S. E., Diouf, A., Tullo, G., Lopera-Mesa, T. M., Bess, C. D., Mita-Mendoza, N. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076734 · Cited by 11
Self-citationDolo, A., Maïga, B., Guindo, A., Diakité, S. A. S., Diakite, M., Tapily, A., Traoré, M., Sangaré, B., Arama, C., Daou, M., et al. (2014) · Bulletin de la Société de pathologie exotique · doi:10.1007/s13149-014-0372-7 · Cited by 8
“protection contre le paludisme au Mali a permis de conclure que le déficit en G6PD (A-) érythrocytaire était associé à la protection contre le paludisme grave aussi bien chez les Malinké que chez les Dogon [6].”
BackgroundInfluentialSelf-citationConroy, A. L., Hawkes, M., Hayford, K. T., Hermann, L. L., McDonald, C. R., Sharma, S., Namasopo, S., Opoka, R. O., John, C. C., Liles, W. C., et al. (2016) · BMC Pediatrics · doi:10.1186/s12887-016-0719-2 · Cited by 8
“Recent estimates of G6PD polymorphisms in Uganda show 20 % of the population carry the G6PD A-mutation [39], which are consistent with the range of estimates 15–32 % described elsewhere in Africa [40–42].”
ResultZhang, Y., Yang, X., He, X., Liu, H., Guo, P., Liu, X., Xiao, Y., Feng, X., Wang, Y., & Li, L. (2019) · Gene · doi:10.1016/j.gene.2019.144027 · Cited by 8
Tabatabaei, S. M., Khorashad, A. S., Sakeni, M., Raeisi, A., & Metanat, Z. (2015) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.5572 · Cited by 8
“5%), which is in agreement with the theory that decreased G6PD enzyme activity is associated with some degree of protection against malaria [24].”
BackgroundCytometric quantification of singlet oxygen in the human malaria parasitePlasmodium falciparum
Butzloff, S., Groves, M. R., Wrenger, C., & Müller, I. B. (2012) · Cytometry Part A · doi:10.1002/cyto.a.22081 · Cited by 7
“Humans with a partially deficient glucose-6-phosphate dehydrogenase activity exhibit a certain degree of protection against malaria (14).”
BackgroundDiakité, M., Miura, K., Diouf, A., Konate, D. S., Keita, A. S., Doumbia, S., Diakité, S. A. S., Traoré, K., Doumbouya, M., Anderson, J. M., et al. (2016) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0125 · Cited by 7
“were genotyped for HbS and HbC, glucose-6-phosphate dehydrogenase (G6PD*A ) deficiency, α-thalassemia, and ABO/Rh blood group antigens as described.(13,14) Using these data, we established a subcohort of 249 children (details”
MethodSelf-citationComparison of severity and prognosis of jaundice due to Rh incompatibility and G6PD deficiency
Zakerihamidi, M., Moradi, A., & Boskabadi, H. (2023) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2023.103714 · Cited by 9
Uyoga, S. M., Macharia, A., Ndila, C., Nyutu, G., Shebe, M., Awuondo, K. O., Mturi, N., Peshu, N. M., Tsofa, B., Scott, J. A. G., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020003015 · Cited by 8
Advances in genetics and genomics: use and limitations in achieving malaria elimination goals
Gunawardena, S., & Karunaweera, N. D. (2015) · Pathogens and Global Health · doi:10.1179/2047773215y.0000000015 · Cited by 9
Beaudry, J., Krause, M., Diakité, S. A. S., Fay, M. P., Joshi, G., Diakité, M., White, N. J., & Fairhurst, R. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092185 · Cited by 11
Self-citationWang, J., Matsuoka, H., Hirai, M., Mu, L., Yang, L., & Luo, E. (2010) · Institutional Repositories DataBase (IRDB) · doi:10.18926/amo/32857 · Cited by 10
“Individuals with G6PD deficiency are relatively resistant to falciparum malaria, and thus there is natural selection for G6PD-deficient people in areas with malignant malaria [34].”
BackgroundOpoku-Okrah, C., Gordge, M. P., Nakua, E. K., Abgenyega, T., Parry, M., Robertson, C. E., & Smith, C. L. (2013) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12122 · Cited by 8
Petit, F., Bailly, P., Chiaroni, J., & Mazières, S. (2016) · Malaria Journal · doi:10.1186/s12936-016-1365-8 · Cited by 8
“The concordance of the geographical distribution of G6PDd variants with lower levels of parasitaemia and reduced risk of infection led to the hypothesis that this enzymatic feature is selectively advantageous in past and present malarial endemic areas [7–10].”
BackgroundAnemia as an impact measure of ITN use among young children
Florey, L. (2012) · Cited by 6
IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children
Samayoa-Reyes, G., Jackson, C. L., Ogolla, S., Sabourin, K. R., Obajemu, A. A., Dent, A. E., Prokunina‐Olsson, L., & Rochford, R. A. (2021) · Malaria Journal · doi:10.1186/s12936-021-03689-z · Cited by 6
Glucose 6-Phosphate Dehydrogenase Deficiency
Qidwai, T. (2021) · Springer eBooks · doi:10.1007/978-981-33-4761-8_7 · Cited by 6
Arese, P., & Gallo, V. (2013) · Springer eBooks · doi:10.1007/978-1-4614-8326-7_5 · Cited by 8
Palasuwan, D., Palasuwan, A., Boonpeng, K., Ketprasit, N., Imwong, M., & Kulkeaw, K. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiab484 · Cited by 5
“A study of children in Mali reported a similar protection associated with both genotypes but not heterozygous females [5].”
BackgroundManjurano, A., Lyimo, E., Kishamawe, C., Omolo, J., Mosha, J., Donald, M., Kazyoba, P., Kapiga, S., & Changalucha, J. (2023) · Malaria Journal · doi:10.1186/s12936-023-04801-1 · Cited by 6
“Despite the haemolytic stress associated with G6PD deficiency there are also reports of protection to malaria afforded by the enzyme deficiency [19, 22].”
BackgroundA contribuição dos polimorfismos humanos do eritrócito na proteção contra a malária
Machado, P., Mendes, C., do Rosário, V. E., & Arez, A. P. (2010) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232010000400013 · Cited by 13
Adaptive immunity selects against malaria infection blocking mutations
Penman, B. S., & Gandon, S. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008181 · Cited by 5
“Some studies have suggested that hemizygous males [68] and perhaps both female heterozyogtes and male hemizygotes for a G6PD deficiency mutation are protected against severe falciparum malaria [69].”
BackgroundElimination of Plasmodium vivax Malaria: Problems and Solutions
Cui, L., Brashear, A., Menezes, L., & Adams, J. H. (2021) · Infectious diseases · doi:10.5772/intechopen.96604 · Cited by 11
Abagero, B. R., Kepple, D., Pestana, K., Witherspoon, L., Biruksew, A., Adanew, A., Baharu, F., Hansel, S., López, K., Janies, D. A., et al. (2022) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2022.966930 · Cited by 6
“vivax parasites preferred to invade younger erythrocytes that possess high levels of G6PD enzyme (53, 54).”
BackgroundNamazzi, R., Mellencamp, K. A., Opoka, R. O., Datta, D., Lima-Cooper, G., Liepmann, C. D., Sherman, J., Rodrı́guez, A., Kazinga, C., Ware, R. E., et al. (2024) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiae431 · Cited by 5
Jajosky, R. P., Wu, S., Jajosky, P. G., & Stowell, S. R. (2023) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed8100478 · Cited by 12
“To further support its potential benefit, there is evidence that the G6PDd phenotype was selected by human evolution because it reduces the risk of severe malaria and death [239–241].”
BackgroundArogbokun, O., Shevik, M. E., Slusher, T. M., Farouk, Z. L., Elfstrum, A. K., Weber, J., Cusick, S. E., & Lund, T. C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75823-x · Cited by 5
Jeremiah, Z. A., Uko, E. K., & Usanga, E. A. (2008) · Journal of Medical Sciences(Faisalabad) · doi:10.3923/jms.2008.269.274 · Cited by 5
Jacques, M. L., Salissou, M. T. M., Kaswiyi, L., Guan, F., & Lei, J. (2019) · Parasitology · doi:10.1017/s0031182019001513 · Cited by 5
“Moreover, additional reports have shown that the interaction between of malaria and HIV potentiated the increase in mortality rate when compared to malaria and HIV seronegative children more especially with associated undernutrition (Amadi et al., 2001; Guindo et al., 2007; Sanyaolu et al., 2013; Kenyon and Buyze, 201…”
BackgroundSakuntabhai, A., Ndiaye, R., Casadémont, I., Peerapittayamongkol, C., Rogier, C., Tortevoye, P., Tall, A., Paul, R. E. L., Turbpaiboon, C., Phimpraphi, W., et al. (2008) · PLoS ONE · doi:10.1371/annotation/d0a416fa-b683-4721-88c1-3f6dc9a04d8d · Cited by 8
Ankyrin-1 Gene Exhibits Allelic Heterogeneity in Conferring Protection Against Malaria
Huang, H., Bauer, D. C., Lelliott, P. M., Dixon, M. W. A., Tilley, L. M., McMorran, B. J., Foote, S. J., & Burgio, G. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300079 · Cited by 6
Ren, N., Kuang, Y., Qiong-Lin, T., Cheng, L., Zhang, C., Yang, Z.-Q., He, Y., & Zhu, Y. (2015) · Medicine · doi:10.1097/md.0000000000001681 · Cited by 4
Intrinsic defects leading to increased erythrocyte destruction
Hodgkins, S. R. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-53045-3.00030-1 · Cited by 7
Naidu, R., Chu, T. T. T., Tripathi, J., Hu, Y., Subramanian, G., Tong, J. X., Tripathi, P., Fang, K., Tan, K. S. W., Lim, C. T., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/862169 · Cited by 6
Reduced cyclin D3 expression in erythroid cells protects against malaria
Marini, M. G., Mingoia, M., Steri, M., Tsamesidis, I., Idda, M. L., Manca, A., D’Avino, C., Virdis, F., Lodde, V., Mulas, A., et al. (2026) · Nature · doi:10.1038/s41586-026-10110-9 · Cited by 5
Jajosky, R. P., Jajosky, A. N., & Jajosky, P. G. (2020) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2020.102824 · Cited by 3
Ogunkanbi, S. O., Adedoyin, O. T., Biliaminu, S. A., & Ernest, S. K. (2019) · Open Journal of Pediatrics · doi:10.4236/ojped.2019.91004 · Cited by 3
“This has been attributed to the partial protection this condition offers against severe malaria, thus conferring a survival advantage on sufferers residing in malaria-endemic regions [1] [2].”
BackgroundImpact of Natural Selection Due to Malarial Disease on Human Genetic Variation
Gomez, F., Ko, W., Davis, A., & Tishkoff, S. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7181-3_5 · Cited by 3
Sánchez, M. C., Villegas, V. E., & Fonseca, D. J. (2008) · TSpace (University of Toronto) · Cited by 3
Host Genetics and Susceptibility to Infection
Cooke, G., Levin, M., Wilkinson, R. J., & Pasvol, G. (2011) · Elsevier eBooks · doi:10.1016/b978-0-7020-3935-5.00006-9 · Cited by 2
Waitumbi, J. N., Kifude, C., W., H., & Ogutu, B. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203455 · Cited by 2
Lamichhane, N., Adhikari, N., Shrestha, U. T., Rijal, K. R., Banjara, M. R., & Ghimire, P. (2018) · Tribhuvan University Journal of Microbiology · doi:10.3126/tujm.v4i0.21680 · Cited by 2
“G6PD is also thought to be a pro tection factor against severe manifestations of malaria, al though studies regarding which individuals, hemizygous males or heterozygous females, may be protected present TUJM VOL. 4, NO. 1, 201773 discrepancies (Ruwende et al. 1995; Guindo et al. 2007).”
BackgroundBotwe, A. K., Oppong, F. B., Gyaase, S., Owusu‐Agyei, S., Asghar, M., Asante, K. P., Färnert, A., & Osier, F. H. A. (2021) · Malaria Journal · doi:10.1186/s12936-021-03752-9 · Cited by 3
“A protective association between G6PD deficiency and malaria through the first year of life may be easier to detect in studies which focus on sex-linkage or malaria-severity [45].”
BackgroundHill, A. V. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-443-06839-3.00005-9 · Cited by 4
Bahk, Y. Y., Ahn, S. K., Jeon, H. J., Na, B., Lee, S., & Shin, H. (2022) · Korean Journal of Parasitology · doi:10.3347/kjp.2022.60.4.281 · Cited by 4
“The distribution of G6PD deficiency correlates with the malaria-endemic areas [11], showing the evolutionary selection of G6PD deficiency by malaria [12].”
BackgroundGlucose‐6‐phosphate Dehydrogenase ( G 6 PD ) Deficiency: Genetics
Mason, P. J., & Vulliamy, T. J. (2010) · Wiley eBooks · doi:10.1002/9780470015902.a0006084.pub2 · Cited by 2
Immunopathology of Malaria in Pregnancy: Immune Cells Response to Infection
Sehgal, R., Malhotra, P., Manhas, P. L., Kaur, U., & Singh, J. (2023) · Journal of Postgraduate Medicine Education and Research · doi:10.5005/jp-journals-10028-1608 · Cited by 1
Insights into Neutrophil Dysfunction in Inherited Metabolic Disorders
Wolf, A., Montanelli, G., Mathis, D., Felser, A., Laemmle, A., Nuoffer, J., Gautschi, M., Bourquin, C., & Stojkov, D. (2026) · Journal of Innate Immunity · doi:10.1159/000552119 · Cited by 2
Chapman, S. J., & Hill, A. V. S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00010-2 · Cited by 1
Metadata
- Authors
- Guindo, A., Fairhurst, R. M., Doumbo, O. K., Wellems, T. E., & Diallo, D. A.
- Affiliations
- National Institutes of Health (US)
- University of Bamako (ML)
- Corresponding author
- Wellems, Thomas E
- Venue
- PLoS Medicine
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-03-13
- Volume
- 4
- Issue
- 3
- Pages
- e66
- ISSN
- 1549-1277 (ISSN-L)
- 1549-1676
- PMC
- PMC1820604
- OpenAlex
- W2020310537
- Cited by
- 272
- References
- 27
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 9 · 2023: 8 · 2022: 20 · 2021: 23 · 2020: 14 · 2019: 16 · 2018: 12 · 2017: 19 · 2016: 12 · 2015: 18 · 2014: 21 · 2013: 14 · 2012: 18
- FWCI
- 15.16
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- NHLBI Division of Intramural Research
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal Health and Biochemistry
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- glucose-6-phosphate dehydrogenase deficiency, severe malaria, Plasmodium falciparum, X-linked inheritance, hemizygous males, heterozygous females, X chromosome inactivation, malaria resistance, cerebral malaria, parasite density, natural selection
- MeSH terms
- Alleles, Child, Child, Preschool, Female, Glucosephosphate Dehydrogenase, Glucosephosphate Dehydrogenase Deficiency, Heterozygote, Humans, Immunity, Innate, Malaria, Male, Mali, Selection, Genetic, Sex Factors, Case-Control Studies, Genetic Diseases, X-Linked, Chromosomes, Human, X, Genes, X-Linked
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.